Immunolines facilitates translational research in and across IMID’s within and outside the UMCG. Our cohorts have as a central goal to increase the understanding of disease mechanisms underlying the immune-mediated diseases including their variety in severity, involved organs and pathways underlying active disease in order to improve early recognition and outcome with targetedtreatment.
- Systemic Lupus Erythematosus and Systemic sclerosis
- Sjögren Expertise Centre
- Vasculitis Expertise Center
- The Groningen Leeuwarden Axiale Spondylartritis (GLAS)
See also: research groups of the UMCG research department Rheumatology and Clinical Immunology
Immunolines will provide an overview of:
UMCG Reumatologie en Klinische Immunologie (in Dutch)
UMCG promotes healthy ageing. To this end the UMCG founded European research institute for the biology of ageing (ERIBA) and supports Lifelines a population based cohort and cohort initiatives. For healthy ageing in IMID’s it is necessary that the patient is recognized in an early stage of the disease before damage occurs. The Immunolines cohort studies and biobanking are in line with the FAIR (findable accessible interoperable reusable) principles, are unique in the world and are perfect for international collaboration and funding. Together with Translational Immunology Groningen (TRIGR) one of the research programs within the Groningen University Institute for Drug Exploration (GUIDE) which aims to unravel the pathophysiological mechanisms underlying immune-mediated chronic diseases and to be a platform for translational immunological research.
University Medical Center Groningen (UMCG)
Immunolines
PO Box 30.001
9700 RB Groningen
The Netherlands
